Nykode Therapeutics

Nykode Therapeutics is at the forefront of biotechnology research, unlocking the future of medicine with its innovative technology platform. Focused on intelligent modular design and tailored hyper-targeting, Nykode Therapeutics is dedicated to pushing the boundaries of medical possibilities. The company operates as a public entity with a team of dedicated professionals committed to advancing healthcare solutions.

Located at Gaustadalléen 21, Oslo, 0349, NO, Nykode Therapeutics specializes in a range of advanced fields, including HPV16, neoepitopes, DNA vaccines, neoantigens, immuno-oncology, oncology, and immunotherapy. With a foundation built in 2007, Nykode Therapeutics continues to expand its impact on the biotechnology landscape through cutting-edge research and development.

Nykode Therapeutics is committed to developing advanced therapies and driving innovation in the biotechnology sector. The company's work is dedicated to improving patient outcomes and transforming the future of medicine. We invite the management team at Nykode Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.